Monoethanolamine

Monoethanolamine

SCHEMBL28333148

CCN(CC)CC.CCN(CC)CC.NCCO.O=P(O)(O)OCC(O)CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LPAR5 Q9H1C0 4/20 0.41
LPAR1 Q92633 7/20 0.38
LPAR4 Q99677 3/20 0.38
LPAR2 Q9HBW0 3/20 0.38
LPAR3 Q9UBY5 3/20 0.38
ENPP2 Q13822 3/20 0.38
LPAR6 P43657 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
PGD P52209 2/20 0.37
PGK1 P00558 1/20 0.36
PGK2 P07205 1/20 0.36
MPI P34949 1/20 0.34
CES2 O00748 1/20 0.34
TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL5181889 0.88 PGD (0.44) LPAR5LPAR1LPAR4LPAR2LPAR3
Monoethanolamine SCHEMBL29242756 0.87 PGD (0.43) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL30277794 0.82 PLA2G2C (0.41) LPAR5SMN1; SMN2
Alcohol SCHEMBL28123008 0.81 LPAR5 (0.51) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL14278848 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL7341 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL7340 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL14278847 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL6655023 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3
SCHEMBL213379 0.79 PGK1 (0.52) LPAR5LPAR1LPAR4LPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110300749-A Compound with somatostatin receptor agonistic activity and medical application thereof 小野药品工业株式会社 2019-10-01 CN disclosed